Abstract
Nanomaterials, with their unique therapeutic traits such as antioxidant, antiinflammatory, antibacterial, antiviral, and anticancer properties, can be used as drug
candidates to treat a wide range of diseases. Nano complexes like dendrimers, carbon
nanotubes, fullerenes, graphene-based nanomaterials, carbon quantum dots,
nanohydrogels, peptide nanostructures, MXenes, Silicene, and Antimonene have been
distinguished by researchers, among the many nanomaterials because of their lower
toxicity, ease of tuning to the desired end use, complex interactions with biological
macromolecules, and solubility properties. This chapter will present the most recent
research details on nanomaterials that have been developed as therapeutic candidates to
treat a number of illnesses.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Drug Delivery Letters
Recent Advances in Anti-Infective Drug Discovery
Applied Drug Research, Clinical Trials and Regulatory Affairs
Current Bioactive Compounds
Current Drug Delivery
Current Drug Safety
Drug Metabolism and Bioanalysis Letters
Recent Advances in Drug Delivery and Formulation
Reviews on Recent Clinical Trials
Related Books
Enzymatic Targets for Drug Discovery Against Alzheimer's Disease
Biotechnology and Drug Development for Targeting Human Diseases
4th International Conference on Drug Discovery and Therapy - 2012
Applied Computer-Aided Drug Design: Models and Methods
Computational Toxicology for Drug Safety and a Sustainable Environment
AI Innovations in Drug Delivery and Pharmaceutical Sciences; Advancing Therapy through Technology
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems
Angiogenesis & Therapeutic Targets In Cancer
Anti-Angiogenesis Drug Discovery and Development
Anti-Angiogenesis Drug Discovery and Development